CanndeoCare (THC Pharma Pty Ltd trading as CanndeoCare) is the primary Australian cannabis medicines brand of THC Global Group Limited (ASX:THC).
CanndeoCare aims to promote accessibility and affordability of medicinal cannabis medicines for Australian patients.
CanndeoCare offers patients access to high quality low cost Pharma GMP medicinal cannabis medicines, and supports prescribers and pharmacies in the responsible and legal prescribing and dispensing of medicinal cannabis medicines to Australian patients.
THC Pharma’s cannabis manufacturing facilities include one of the world’s largest pharmaceutical biofloral extraction facilities, capable of producing significant volumes of pharmaceutical grade TGA GMP medicines